Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OHAUS Explorer®: “Touchless” Sensors

Published: Wednesday, August 08, 2012
Last Updated: Wednesday, August 08, 2012
Bookmark and Share
Practical touchless sensors improve weighing efficiency and prolong instrument life.

The Explorer series of analytical and precision balances from OHAUS Corporation, a leading worldwide manufacturer of balances and scales, features four user programmable touchless sensors.

Ideal for laboratory applications, the sensors free lab technicians’ hands and reduce wear and tear on the balance while preventing a loss of focus when delicate or critical samples are being weighed.

The two programmable sensors on the base and two on the display can be setup individually to offer hands-free operation of tare, zero, print, calibration and other functions to minimize cross-contamination or unwanted residue on the balance.

Simultaneously, the ingeniously practical sensors prolong the life of the instrument by minimizing the need to press the keypad with a hand, tool or foreign object.

In addition to keeping the balance clean and minimizing damage, the sensors improve weighing speed and efficiency in the laboratory.

A simple wave of the hand over the touchless sensors eliminates the extra effort or time to press the keys.

The Explorer’s other advanced features include OHAUS’ recently enhanced SmarText™ 2.0 easy-to-use graphical software, a fully-automatic internal calibration system, intuitive user setup and modular design in which the display can be separated from the weighing base for maximum flexibility.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Sensor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!